BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 38567612)

  • 21. Advances in Alzheimer's disease: A multifaceted review of potential therapies and diagnostic techniques for early detection.
    Sharma M; Pal P; Gupta SK
    Neurochem Int; 2024 Jul; 177():105761. PubMed ID: 38723902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of vilazodone-donepezil chimeric derivatives as acetylcholinesterase inhibitors by QSAR, molecular docking and molecular dynamics simulations.
    Guo L; Chang Z; Tong J; Gao P; Zhang Y; Liu Y; Yang Y; Wang C
    Phys Chem Chem Phys; 2024 Jun; ():. PubMed ID: 38896464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro anti-acetylcholinesterase activity of an aqueous extract of Unicaria tomentosa and in silico study of its active constituents.
    Chowdhury S; Shivani ; Kumar S
    Bioinformation; 2016; 12(3):112-118. PubMed ID: 28149044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phytochemical constituents analysis in
    Adella Putri AD; Sembiring MH; Tuba S
    Commun Integr Biol; 2024; 17(1):2357346. PubMed ID: 38798825
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Karthick K; Abishek K; Angel Jemima E
    Bioinform Biol Insights; 2024; 18():11779322241247635. PubMed ID: 38854784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
    Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
    Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
    Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Kovaleva NV; Yu Astakhova T; Boltneva NP; Rudakova EV; Serebryakova OG; Proshin AN; Serkov IV; Trofimova TP; Tafeenko VA; Radchenko EV; Palyulin VA; Fisenko VP; Korábečný J; Soukup O; Richardson RJ
    Bioorg Chem; 2021 Jul; 112():104974. PubMed ID: 34029971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
    Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z
    Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of Benzimidazole-Based Analogs as Anti Alzheimer's Disease Compounds and Their Molecular Docking Studies.
    Adalat B; Rahim F; Taha M; Alshamrani FJ; Anouar EH; Uddin N; Shah SAA; Ali Z; Zakaria ZA
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33092223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential acetylcholinesterase inhibitors to treat Alzheimer's disease.
    Saud A; Krishnaraju V; Taha A; Kalpana K; Malarkodi V; Durgaramani S; Vinoth Prabhu V; Saleh FA; Ezhilarasan S
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2522-2537. PubMed ID: 38567612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
    Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
    Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fused thiophene as a privileged scaffold: A review on anti-Alzheimer's disease potentials via targeting cholinesterases, monoamine oxidases, glycogen synthase kinase-3, and Aβ aggregation.
    Kassab AE; Gedawy EM; Sayed AS
    Int J Biol Macromol; 2024 Apr; 265(Pt 2):131018. PubMed ID: 38518928
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.